» Articles » PMID: 35329054

Assessment of CVD Risk Factors in Secondary Prevention After Ischemic Stroke Using the ICF

Overview
Publisher MDPI
Date 2022 Mar 25
PMID 35329054
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients after undergoing ischemic stroke have a high risk of further cardiovascular disease (CVD) incidents. Monitoring risk factors is critical to prevent the recurrence of CVD. Objective: The aim of the study was to determine differences in the incidence of risk factors for CVD in a post-ischemic stroke patient group (SG) compared to the control group, which had not undergone ischemic stroke (CG), and to characterize them using the ICF (International Classification of Functioning, Disability and Health) classification system. Materials and Methods: The incidence of risk factors for recurrent CVD events were retrospectively analyzed in 55 patients in SG and 55 patients in CG. The results were translated into categories from the ICF classification system. Results: Atrial fibrillation (p = 0.013), carotid artery stenosis > 50% (p < 0.001), LDL > 71 mg/dL (p < 0.001), heart rate > 80/min (p = 0.007), taking NOAC (p = 0.008) and NSAIDs (p < 0.001) as well as nicotinism (p = 0.001) were significantly more common in SG compared to CG. The value of the distribution of the total incidence of CVD risk factors were observed to be higher for SG than for CG. In SG, both for males (p < 0.001) and females (p < 0.001) more risk factors for recurrent CVD incidents were observed compared to CG. Conclusions: Patients in SG differ in the occurrence of risk factors for CVD event compared to CG. The use of a single tool, such as the ICF assessment sheet, can be useful in assessing and analyzing risk factors for recurrent CVD events. This may help to reduce the risk of subsequent CVD events in secondary prevention.

Citing Articles

Risk factors for multiple recurrent ischemic strokes.

Uzuner N, Tekgol Uzuner G Brain Circ. 2023; 9(1):21-24.

PMID: 37151788 PMC: 10158663. DOI: 10.4103/bc.bc_73_22.

References
1.
Skajaa N, Adelborg K, Horvath-Puho E, Rothman K, Henderson V, Thygesen L . Risks of Stroke Recurrence and Mortality After First and Recurrent Strokes in Denmark: A Nationwide Registry Study. Neurology. 2021; 98(4):e329-e342. DOI: 10.1212/WNL.0000000000013118. View

2.
Pisters R, Lane D, Nieuwlaat R, de Vos C, Crijns H, Lip G . A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010; 138(5):1093-100. DOI: 10.1378/chest.10-0134. View

3.
Zhang J, Wang Y, Wang G, Sun H, Sun T, Shi J . Clinical factors in patients with ischemic versus hemorrhagic stroke in East China. World J Emerg Med. 2014; 2(1):18-23. PMC: 4129741. DOI: 10.5847/wjem.j.1920-8642.2011.01.003. View

4.
Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M . Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2014; 38(1):140-9. DOI: 10.2337/dc14-2441. View

5.
Weiner D, Tighiouart H, Stark P, Amin M, MacLeod B, Griffith J . Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004; 44(2):198-206. DOI: 10.1053/j.ajkd.2004.04.024. View